Artiva Biotherapeutics (ARTV) Leases: 2023-2025
Historic Leases for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2025 value amounting to $11.3 million.
- Artiva Biotherapeutics' Leases fell 21.66% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year decrease of 21.66%. This contributed to the annual value of $13.8 million for FY2024, which is 16.64% down from last year.
- Artiva Biotherapeutics' Leases amounted to $11.3 million in Q3 2025, which was down 11.39% from $12.7 million recorded in Q2 2025.
- Over the past 5 years, Artiva Biotherapeutics' Leases peaked at $16.5 million during Q4 2023, and registered a low of $11.3 million during Q3 2025.
- For the 3-year period, Artiva Biotherapeutics' Leases averaged around $13.9 million, with its median value being $13.8 million (2024).
- Data for Artiva Biotherapeutics' Leases shows a maximum YoY declined of 21.66% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Artiva Biotherapeutics' Leases stood at $16.5 million in 2023, then dropped by 16.64% to $13.8 million in 2024, then dropped by 21.66% to $11.3 million in 2025.
- Its Leases stands at $11.3 million for Q3 2025, versus $12.7 million for Q2 2025 and $13.5 million for Q1 2025.